Movement Alert|Synopsys Rises 3.13% in Pre-Market Trading, Elliott Representative Officially Joins Board as Multiple Firms Raise Target Prices

Market Focus
06/01

On June 1, Synopsys rose 3.13% in pre-market trading, trading at $490.5/share, with trading volume of approximately $2.75 million.

On the news front, activist investor Elliott Investment Management's representative Jesse Cohn officially joined Synopsys' board of directors on June 1, expanding the board to 11 members. Under the cooperation agreement, Elliott has committed to customary standstill provisions, pledging not to increase its stake beyond 4.9% or maintain economic exposure exceeding 7.5%. Additionally, following the company's Q2 earnings release showing revenue of $22.76 billion (up 42% YoY) and adjusted EPS of $3.35 beating consensus of $3.15, multiple institutions raised their target prices — Citi lifted its target to $610 maintaining a Buy rating, while Rosenblatt raised to $575 also maintaining Buy. HSBC also adjusted its target from $460 to $490.

After a post-earnings pullback from approximately $527 to around $490, the formal board appointment catalyzing governance optimization expectations, combined with broad institutional bullish consensus, drove the pre-market rebound.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10